期刊文献+

甲钴胺治疗糖尿病周围神经病变疗效分析 被引量:5

Observation of the effect of methylcobalamin in the treatment of diabetic peripheral neuropathy
暂未订购
导出
摘要 目的观察甲钴胺(商品名:甲钴胺)治疗糖尿病周围神经病变(DPN)的临床疗效。方法80例糖尿病周围神经病变患者随机分为治疗组和对照组各40例。治疗组给予注射用甲钴胺1mg加入生理盐水250ml静脉滴注(避光),每天1次;对照组给予丹参注射液混合液250ml静脉滴注,每天1次,2组均连用14d为1个疗程,使用2个疗程。分别测定2组治疗前后患侧腓总神经、胫神经运动传导速度和感觉传导速度以及Hoffinan(H-反射)。结果治疗组患侧腓总神经、胫神经运动传导速度和感觉传导速度高于治疗前,H-反射低于治疗前,差异均有统计学意义(P<0.05),对照组治疗后较治疗前无明显改善(P>0.05),2组治疗后各观察指标比较差异有统计学意义(P<0.05)。结论甲钴胺对DPN有良好的治疗效果。 Objective To observe the effect of methylcobalamin for diabetic periferal neuropathy(DPU). Methods 80 patients with DPU were randomly divided into treament group and control group,40 cases of each. The treatment group was given methylcobalamin injection 1 mg intravenous drip once a day,while patients in the control group was given danshen injection 250ml intravenous drip once a day. Continued 14 days for a course of treatment,and used for two courses. The nerve conductive velocity(NVC) of the tibial nerve and the common peroneal nerve were examined pre and post treatment, as well as hoffman reflex. Results After treatment for 4 weeks, there was a significant difference in MCV ,SCV and hoffinan between pre and post treatment in the treatment group,The differences were statistically significant ( P 〈 0.05 ) , while no difference in the control group( P 〉 0.05 ). There was significant difference between the indicators of two groups (P 〈 0.05 ). Conclusion Methylcobalamin has good therapeutic effect in treating diabetic periferal neuropathy.
出处 《临床合理用药杂志》 2009年第24期34-35,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 甲钴胺 丹参 糖尿病周围神经病变 Methylcobalamin Danshen injection Diabetic peripheral neuropathy
  • 相关文献

参考文献2

二级参考文献17

共引文献149

同被引文献27

  • 1刘丽君,贺佩祥.红花注射液与甲钴胺联合治疗糖尿病周围神经病变[J].临床荟萃,2005,20(3):164-165. 被引量:6
  • 2李莉,贾钰,刘萍.易善复药液与其他注射液存在配伍禁忌[J].中国实用护理杂志(下旬版),2007,23(2):37-37. 被引量:4
  • 3徐叔云.临床药理学[M].第3版.北京:人民卫生出版社,2005:431.
  • 4Barta J,Sanganalmath SK,Kumamoto H,et al.Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality[J].Cardiovasc Toxicol,2008,8(3):127-35.
  • 5Roten L,Schoenenberger RA,Krahenbuhl S.Rhabdomyolysis in association with simvastatin and amiodarone[J].Ann Pharmacother,2004,38(6):978-81.
  • 6Vileikyte L,Peyrot M,Gonzalez JS,et al.Predictors of depressive symptoms in persons with diabetic peripheral neuropathy:a longitudinal study.Diabetologia,2009,52(7):1265-1273.
  • 7Malik RA, Tesfaye S, Thompson SD, et al.Endoneuriallocalization of microvascular damage in human diabetic neuropoathy. Diabetologia. 1993, 36:454-459.
  • 8Malik RA, Newrick PJ, Sharma AK, et al.microangiopathy in human diabetic neuropathy: relationship between capillary abnormalties and the severity of neuropathy. Diabetologia. 1989, 32 (2) :92-102.
  • 9Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabeticpolyneuropathy and are associated with its severity. Ann Neurol. 1995, 37 (4) : 498-504.
  • 10燕宇.丹参注射液治疗糖尿病合并脑缺血64例临床观察.中国保健营养(中旬刊),2012(11):74-75.

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部